Related Experiment Video
Updated: Jun 23, 2025

Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesterol inhibits assembly and activation of the EphA2 receptor
Ryan J Schuck1, Alyssa E Ward1, Amita R Sahoo2
1Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, USA.
Abstract:
The receptor tyrosine kinase EphA2 drives cancer malignancy by facilitating metastasis. EphA2 can be found in different self-assembly states: as a monomer, dimer, and oligomer. However, our understanding remains limited regarding which EphA2 state is responsible for driving pro-metastatic signaling. To address this limitation, we have developed SiMPull-POP, a single-molecule method for accurate quantification of membrane protein self-assembly. Our experiments revealed that a reduction of plasma membrane cholesterol strongly promoted EphA2 self-assembly. Indeed, low cholesterol caused a similar effect to the EphA2 ligand ephrinA1-Fc. These results indicate that cholesterol inhibits EphA2 assembly. Phosphorylation studies in different cell lines revealed that low cholesterol increased phospho-serine levels, the signature of oncogenic signaling. Investigation of the mechanism that cholesterol uses to inhibit the assembly and activity of EphA2 indicate an in-trans effect, where EphA2 is phosphorylated by protein kinase A downstream of beta-adrenergic receptor activity, which cholesterol also inhibits. Our study not only provides new mechanistic insights on EphA2 oncogenic function, but also suggests that cholesterol acts as a molecular safeguard mechanism that prevents uncontrolled self-assembly and activation of EphA2.
Insights
Cholesterol inhibits the self-assembly and oncogenic signaling of the receptor tyrosine kinase EphA2, which drives cancer metastasis. Lowering cholesterol promotes EphA2 assembly and activation, suggesting cholesterol acts as a safeguard.
Area of Science:
- Molecular biology
- Cell biology
- Cancer research
Background:
- The receptor tyrosine kinase EphA2 promotes cancer metastasis.
- EphA2 exists in monomer, dimer, and oligomer states, but the pro-metastatic signaling state is unknown.
Purpose of the Study:
- To investigate the role of EphA2 self-assembly states in driving pro-metastatic signaling.
- To develop a method for quantifying membrane protein self-assembly.
- To elucidate the mechanism by which cholesterol affects EphA2 assembly and activity.
Main Methods:
- Developed SiMPull-POP, a single-molecule method for quantifying membrane protein self-assembly.
- Performed experiments involving plasma membrane cholesterol reduction.
- Conducted phosphorylation studies in various cell lines.
- Investigated the mechanism of cholesterol's effect on EphA2 assembly and activity.
Main Results:
- Reduced plasma membrane cholesterol strongly promoted EphA2 self-assembly, mimicking the effect of the EphA2 ligand.
- Cholesterol was found to inhibit EphA2 assembly.
- Low cholesterol increased phospho-serine levels, a marker of oncogenic signaling.
- Cholesterol inhibits EphA2 assembly and activity via an in-trans effect involving protein kinase A and beta-adrenergic receptor signaling.
Conclusions:
- Cholesterol inhibits EphA2 self-assembly and activation, thereby preventing uncontrolled oncogenic signaling.
- Cholesterol acts as a molecular safeguard against EphA2-driven pro-metastatic signaling.
- These findings provide new mechanistic insights into EphA2's oncogenic function.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cholesterol: Significance and Regulation
Considering cholesterol and...
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Receptor-mediated Endocytosis
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...

